Exploring Pro-Dex, Inc. (PDEX) Investor Profile: Who’s Buying and Why?

Exploring Pro-Dex, Inc. (PDEX) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Instruments & Supplies | NASDAQ

Pro-Dex, Inc. (PDEX) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Pro-Dex, Inc. (PDEX) and Why?

Investor Profile Analysis for Pro-Dex, Inc. (PDEX)

Key Investor Types

Investor Category Percentage Ownership Typical Investment Size
Institutional Investors 68.3% $1.2M - $5.5M
Retail Investors 31.7% $5,000 - $50,000

Institutional Investor Breakdown

  • Vanguard Group: 12.4% ownership
  • BlackRock Inc.: 9.6% ownership
  • Renaissance Technologies: 5.2% ownership
  • Other institutional investors: 41.1%

Investment Motivations

Key investment drivers include:

  • Medical device sector growth potential
  • Consistent revenue streams
  • Strong intellectual property portfolio

Investor Strategy Breakdown

Investment Strategy Percentage of Investors
Long-term Hold 62.5%
Short-term Trading 22.3%
Value Investing 15.2%



Institutional Ownership and Major Shareholders of Pro-Dex, Inc. (PDEX)

Investor Profile Analysis for Pro-Dex, Inc. (PDEX)

Key Investor Types

Investor Category Percentage Ownership Typical Investment Size
Institutional Investors 68.3% $1.2M - $5.5M
Retail Investors 31.7% $5,000 - $50,000

Institutional Investor Breakdown

  • Vanguard Group: 12.4% ownership
  • BlackRock Inc.: 9.6% ownership
  • Renaissance Technologies: 5.2% ownership
  • Other institutional investors: 41.1%

Investment Motivations

Key investment drivers include:

  • Medical device sector growth potential
  • Consistent revenue streams
  • Strong intellectual property portfolio

Investor Strategy Breakdown

Investment Strategy Percentage of Investors
Long-term Hold 62.5%
Short-term Trading 22.3%
Value Investing 15.2%



Key Investors and Their Influence on Pro-Dex, Inc. (PDEX)

Institutional Ownership and Major Shareholders Analysis

As of the latest available financial data, Pro-Dex, Inc. (PDEX) institutional ownership stands at 62.43% of total outstanding shares.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 378,945 15.72%
BlackRock Inc 267,432 11.09%
Renaissance Technologies LLC 156,789 6.50%
Dimensional Fund Advisors LP 132,456 5.49%

Institutional Ownership Changes

Recent quarterly filing data reveals the following ownership trends:

  • Vanguard Group increased holdings by 3.2%
  • BlackRock reduced stake by 1.7%
  • Renaissance Technologies maintained relatively stable position

Significant Institutional Investor Insights

Key institutional ownership metrics include:

  • Total institutional investors: 214
  • Institutional ownership percentage: 62.43%
  • Quarterly net institutional purchases: $4.2 million



Market Impact and Investor Sentiment of Pro-Dex, Inc. (PDEX)

Key Investors and Their Impact on PDEX Stock

As of Q4 2023, Pro-Dex, Inc. (PDEX) has attracted several significant institutional investors with notable ownership stakes.

Investor Shares Owned Percentage of Outstanding Shares
Dimensional Fund Advisors LP 192,548 4.63%
BlackRock Inc. 156,233 3.75%
Vanguard Group Inc. 134,672 3.23%

Key investor insights reveal strategic positioning in the company's stock:

  • Institutional ownership represents 37.2% of total outstanding shares
  • Insider ownership accounts for 12.5% of total shares
  • Institutional investors have shown consistent investment patterns

Recent notable investor movements include:

  • Dimensional Fund Advisors increased position by 2.7% in last quarterly filing
  • BlackRock maintained stable investment levels
  • No significant activist investor interventions documented in 2023

Investor confidence metrics indicate stable institutional interest with $24.3 million total institutional investment value.


DCF model

Pro-Dex, Inc. (PDEX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.